Application 062982

Type
ANDA
Sponsor
DAVA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMPICILLIN TRIHYDRATEAMPICILLIN/AMPICILLIN TRIHYDRATEFOR SUSPENSION;ORALEQ 125MG BASE/5MLNoNo
002AMPICILLIN TRIHYDRATEAMPICILLIN/AMPICILLIN TRIHYDRATEFOR SUSPENSION;ORALEQ 250MG BASE/5MLNoYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062982-001AMPICILLIN TRIHYDRATEAMPICILLIN/AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10
A062982-002AMPICILLIN TRIHYDRATEAMPICILLIN/AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062982-001AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-103a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062982-002AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-103a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062982-001AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A062982-002AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A062982-001AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10e64feba35796…
2022-09-29 23:25 UTC2022-09A062982-002AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A062982-001AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A062982-002AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A062982-001AMPICILLIN TRIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A062982-002AMPICILLIN TRIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORAL1989-02-10a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
67253-182AmpicillinAmpicillinPar PharmaceuticalANDACurrent
67253-182AmpicillinAmpicillinPar PharmaceuticalANDACurrent
67253-183AmpicillinAmpicillinPar PharmaceuticalANDACurrent
67253-183AmpicillinAmpicillinPar PharmaceuticalANDACurrent